These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 17175234

  • 21. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK, Plummer MS, Hilton G, Pieper GM, Ledbetter S.
    Circulation; 2004 Dec 21; 110(25):3822-9. PubMed ID: 15583082
    [Abstract] [Full Text] [Related]

  • 22. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 21; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 23. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N, Torras J, Alperovich G, Cruzado JM, Giménez-Bonafé P, Herrero-Fresneda I, Franquesa Ml, Rama I, Grinyó JM.
    Nephrol Dial Transplant; 2008 Oct 21; 23(10):3111-9. PubMed ID: 18469305
    [Abstract] [Full Text] [Related]

  • 24. [Antisense TGF-beta 1 transfection decreases acute and chronic rejection in allografts].
    Redaelli CA, Schilling MK, Hullett DA, Büchler MW, Sollinger HW.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Oct 21; 115(Suppl I):699-704. PubMed ID: 14518344
    [Abstract] [Full Text] [Related]

  • 25. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
    Savikko J, Teppo AM, Taskinen E, von Willebrand E.
    Transpl Immunol; 2014 Sep 21; 31(3):145-51. PubMed ID: 25158212
    [Abstract] [Full Text] [Related]

  • 26. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    Schrepfer S, Deuse T, Sultan KR, Haddad M, Böger R, Münzel T, Schäfer H, Pelletier MP, Robbins RC, Reichenspurner H.
    Cardiology; 2007 Nov 15; 108(2):128-37. PubMed ID: 17028423
    [Abstract] [Full Text] [Related]

  • 28. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
    Matl I, Viklický O, Voska L, Lodererová A, Vítko S.
    Transpl Int; 2005 Jun 15; 18(6):668-71. PubMed ID: 15910291
    [Abstract] [Full Text] [Related]

  • 29. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W, Schneeberger S, Seiler R, Stroka DM, Amberger A, Offner F, Candinas D, Margreiter R.
    Transplantation; 2003 Apr 15; 75(7):940-5. PubMed ID: 12698077
    [Abstract] [Full Text] [Related]

  • 30. Molecular and structural consequences of early renal allograft injury.
    Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.
    Kidney Int; 2002 Feb 15; 61(2):686-96. PubMed ID: 11849412
    [Abstract] [Full Text] [Related]

  • 31. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
    du Toit D, Muller C, Page B, Louw J.
    Microsc Res Tech; 1998 Nov 15; 43(4):347-55. PubMed ID: 9849976
    [Abstract] [Full Text] [Related]

  • 32. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK, Lemström KB, Häyry PJ.
    Am J Pathol; 1995 Apr 15; 146(4):972-80. PubMed ID: 7536397
    [Abstract] [Full Text] [Related]

  • 33. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
    Savikko J, Kallio EA, Taskinen E, von Willebrand E.
    Transplantation; 2002 Feb 27; 73(4):506-11. PubMed ID: 11889420
    [Abstract] [Full Text] [Related]

  • 34. Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.
    Zonta S, Alessiani M, Viganò J, Doni M, Bardone M, Dominioni T, De Martino M, Scaglione M, Vicini E, Filisetti C, Biroli A, Bottazzi A, Villa C, Morbini P, Dionigi P.
    Transplant Proc; 2007 Feb 27; 39(6):2021-3. PubMed ID: 17692681
    [Abstract] [Full Text] [Related]

  • 35. A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs.
    Jin MB, Nakayama M, Ogata T, Fujita M, Mino K, Taniguchi M, Suzuki T, Shimamura T, Furukawa H, Todo S.
    Surgery; 2002 Jul 27; 132(1):72-9. PubMed ID: 12110798
    [Abstract] [Full Text] [Related]

  • 36. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec 27; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 37. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.
    J Heart Lung Transplant; 2006 Jul 27; 25(7):825-33. PubMed ID: 16818126
    [Abstract] [Full Text] [Related]

  • 38. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ, Bicknell GR, Nicholson ML.
    Transpl Int; 2003 May 27; 16(5):347-53. PubMed ID: 12759727
    [Abstract] [Full Text] [Related]

  • 39. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    Schrepfer S, Deuse T, Schäfer H, Reichenspurner H.
    Transpl Int; 2005 Feb 27; 18(2):215-20. PubMed ID: 15691275
    [Abstract] [Full Text] [Related]

  • 40. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I, Khan ZA, Lian D, Jiang J, Zhong R, Garcia B, Chakrabarti S.
    Transplantation; 2006 Aug 15; 82(3):406-14. PubMed ID: 16906041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.